LXXGF News and Press, Lexagene Holdings From 06/29/21

LexaGene Holdings Inc. (LXXGF): Q4 GAAP EPS of -$0.10.Revenue of $0.06MShares -2.51%.Press Release For further details see: LexaGene Holdings Inc. reports Q4 results

BEVERLY, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that the Company fi...

BEVERLY, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ), (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it has retained LaVoie...

BEVERLY, Mass., June 24, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced Meridian Veterinary Capital, LLC (“Meridian ...

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified investors throughout the thr...

BEVERLY, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) a molecular diagnostics company, is pleased to announce that today, Dr. Jack Regan, CEO and Founder of LexaGene, will present at the Biothreat and Pathogen Detection Co...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2021 – Dogs have always been man’s best friend, but the amount of money pet owners are shelling out for their four-legged friends has grown substantially over the years. ...

BEVERLY, Mass., June 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ), a molecular diagnostics company, announced the Company has sold another MiQLab ™ System and the CEO will present at multiple conferences. LexaGene CEO...

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF) , a molecular diagnostics company that develops fully automated, rapid pathogen detection systems, today announced it has successfully utilized the MiQLab(TM) system to detect the presence of a slow-growing bacterium responsible for millions of ...

MiQLab detects 100% of C. acnes samples 36-times faster than a culture started from ideal laboratory conditions (in 2 hours versus 3 days) MiQLab can be as much as 168-times faster than a culture started from a bioreactor sample (2 hours versus 14 days) Adopting MiQLab...